TY - JOUR
T1 - Expression, action, and steroidal regulation of insulin like growth factor-I (IGF-I) and IGF-I receptor in the rat corpus luteum
T2 - Their differential role in the two cell populations forming the corpus luteum
AU - Parmer, T. G.
AU - Roberts, C. T.
AU - Leroith, D.
AU - Adashi, E. Y.
AU - Khanf, I.
AU - Solan, N.
AU - Nelson, S.
AU - Zilberstein, M.
AU - Gibori, G.
PY - 1991/12
Y1 - 1991/12
N2 - The overall aim of this investigation was to examine the expression and steroidal regulation of insulin-like growth factor-I (IGF-I)and the IGF-I receptor in the rat corpus luteum and to examine the specificity of IGF-I action in the two luteal cell populations. We first examined whether the corpus luteum expresses the IGF-I and IGF-I receptor genes. Using a solution hybridization/RNase protection assay, IGF-I and IGF-I receptor mRNAs were represented by protected bands 224 and 265 bases in length, respectively. In addition, Northern blot analysis showed that, as in liver, rat IGF-I and IGF-I receptor cDNAs hybridized with 7.5-, 1.8-, and 0.8-to 1.2-kilobase tran-scripts and an 11-kilobase transcript, respectively. Both IGF-I and IGF-I receptor mRNAs were detected on all days of pregnancy tested (days 5-21). Since the rat corpus luteum increases remarkably in size and steroidogenic capacity at midpregnancy due to estradiol stimulation, we determined whether these developmental changes are accompanied by an increased expression of the IGF-I and/or IGF-I receptor genes. Total RNA was isolated from corpora lutea of day 12 hypophysectomized-hys-terectomized rats treated with or without estradiol for 3 days. Estradiol caused a clear and marked reduction in IGF-I and IGF-I receptor mRNA. [125I]IGF-I bound with high specificity and affinity to luteal cell membranes. Large and small cell populations forming corpora lutea of day 3 and14 pregnant rats were separated by elutriation and used for the determination of binding activity and for cell culture, respectively. IGF-I receptors were found to be localized principally in the large luteal cell population. The small luteal cells had approximately 6.5-fold less IGF-I-binding activity. The difference in binding activity in both cell populations was reflected in the ability ofboth cell types to respond to IGF-I. IGF-I (25 ng/ml) had a profound effect on the production of progesterone by the large luteal cells. No stimulatory effect of IGF-I on the small luteal cells was observed. Addition of estradiol (10 ng/ml) to the cell culture remarkably enhanced IGF-I stimulation of progesterone biosynthesis by the large luteal cells. In summary, the results of this investigation have revealed that the corpus luteum of the pregnant rat is a major site of expression of both the IGF-I and IGF-I receptor genes. It is the large luteal cells forming the corpus luteum that contain the majority of IGF-I receptors and respond to IGF-I with an increase in steroidogenic output. These results also suggest that whereas IGF-I may play a role in luteal cell function, it does not appear to be responsible for the increase in size and steroidogenic capacity that occurs in the corpus luteum at midpregnancy andwhich is induced by estradiol.
AB - The overall aim of this investigation was to examine the expression and steroidal regulation of insulin-like growth factor-I (IGF-I)and the IGF-I receptor in the rat corpus luteum and to examine the specificity of IGF-I action in the two luteal cell populations. We first examined whether the corpus luteum expresses the IGF-I and IGF-I receptor genes. Using a solution hybridization/RNase protection assay, IGF-I and IGF-I receptor mRNAs were represented by protected bands 224 and 265 bases in length, respectively. In addition, Northern blot analysis showed that, as in liver, rat IGF-I and IGF-I receptor cDNAs hybridized with 7.5-, 1.8-, and 0.8-to 1.2-kilobase tran-scripts and an 11-kilobase transcript, respectively. Both IGF-I and IGF-I receptor mRNAs were detected on all days of pregnancy tested (days 5-21). Since the rat corpus luteum increases remarkably in size and steroidogenic capacity at midpregnancy due to estradiol stimulation, we determined whether these developmental changes are accompanied by an increased expression of the IGF-I and/or IGF-I receptor genes. Total RNA was isolated from corpora lutea of day 12 hypophysectomized-hys-terectomized rats treated with or without estradiol for 3 days. Estradiol caused a clear and marked reduction in IGF-I and IGF-I receptor mRNA. [125I]IGF-I bound with high specificity and affinity to luteal cell membranes. Large and small cell populations forming corpora lutea of day 3 and14 pregnant rats were separated by elutriation and used for the determination of binding activity and for cell culture, respectively. IGF-I receptors were found to be localized principally in the large luteal cell population. The small luteal cells had approximately 6.5-fold less IGF-I-binding activity. The difference in binding activity in both cell populations was reflected in the ability ofboth cell types to respond to IGF-I. IGF-I (25 ng/ml) had a profound effect on the production of progesterone by the large luteal cells. No stimulatory effect of IGF-I on the small luteal cells was observed. Addition of estradiol (10 ng/ml) to the cell culture remarkably enhanced IGF-I stimulation of progesterone biosynthesis by the large luteal cells. In summary, the results of this investigation have revealed that the corpus luteum of the pregnant rat is a major site of expression of both the IGF-I and IGF-I receptor genes. It is the large luteal cells forming the corpus luteum that contain the majority of IGF-I receptors and respond to IGF-I with an increase in steroidogenic output. These results also suggest that whereas IGF-I may play a role in luteal cell function, it does not appear to be responsible for the increase in size and steroidogenic capacity that occurs in the corpus luteum at midpregnancy andwhich is induced by estradiol.
UR - http://www.scopus.com/inward/record.url?scp=0025840503&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025840503&partnerID=8YFLogxK
U2 - 10.1210/endo-129-6-2924
DO - 10.1210/endo-129-6-2924
M3 - Article
C2 - 1659518
AN - SCOPUS:0025840503
SN - 0013-7227
VL - 129
SP - 2924
EP - 2932
JO - Endocrinology
JF - Endocrinology
IS - 6
ER -